Hypercalcaemia of malignancy and Mitral valve replacement

Summary:

Mitral valve replacement is found among people with Hypercalcaemia of malignancy, especially for people who are female, 50-59 old.

The study analyzes which people have Mitral valve replacement with Hypercalcaemia of malignancy. It is created by eHealthMe based on reports of 12 people who have Hypercalcaemia of malignancy from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Hypercalcaemia of malignancy?

Hypercalcaemia of malignancy (elevated calcium (ca+) level in the blood with cancer) is found to be associated with 88 drugs and 111 conditions by eHealthMe. Check the latest studies of Hypercalcaemia of malignancy.

What is Mitral valve replacement?

Mitral valve replacement is found to be associated with 94 drugs and 161 conditions by eHealthMe. Check the latest studies of Mitral valve replacement.

On Jul, 25, 2026

12 people who have Hypercalcaemia Of Malignancy and Mitral Valve Replacement are studied.

Would you have Mitral valve replacement when you have Hypercalcaemia of malignancy?

Gender of people who have Hypercalcaemia Of Malignancy and experienced Mitral Valve Replacement *:

female: 100 %
male: 0.0 %

Age of people who have Hypercalcaemia Of Malignancy and experienced Mitral Valve Replacement *:

Common co-existing conditions for these people *:

Multiple Myeloma (cancer of the plasma cells): 12 people, 100.00%
Hypercalcaemia (elevated calcium (ca+) level in the blood): 12 people, 100.00%

Common drugs taken by these people *:

Common symptoms for these people *:

X-Ray Abnormal: 12 people, 100.00%
Pain In Jaw: 12 people, 100.00%
Biopsy Bone Abnormal: 12 people, 100.00%
Bone Disorder: 12 people, 100.00%
Cardiac Arrest: 12 people, 100.00%
Impaired Healing: 12 people, 100.00%
Infection: 12 people, 100.00%
Jaw Fracture: 12 people, 100.00%
Joint Dislocation (a joint position is changed from normal position): 12 people, 100.00%
Osteolysis (dissolution of bone): 12 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Mitral valve replacement?

- Check whether Mitral valve replacement is associated with a drug or a condition

Related studies:

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Mitral valve replacement and Hypercalcaemia of malignancy, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.